Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 26, 2026, titled "Submission of press release that Eugia Pharma receives USFDA Approval for Everolimus Tablets.".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 26, 2026, titled "Submission of press release that Eugia Pharma receives USFDA Approval for Everolimus Tablets.".